David Liebeskind, MD
Neurology · Los Angeles, CANPI 1629093091
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,813,790 of the $1,934,302 with a category attached, or 93.8%. 23 manufacturers reported payments, led by Medical Device Business Services, Inc. at 56.1% of the total. Among neurology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 344 payments — averaging $5622.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$1.1M
- Stryker$404K
- Genentech, Inc.$164K
- Siemens Medical Solutions USA, Inc.$148K
- AstraZeneca$40K
- Silk Road Medical, Inc.$25K
- plus $67K from 17 others
Across 74 payments — averaging $30,232 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$815K
- Amgen$601K
- Route 92 Medical, Inc.$334K
- Genentech, Inc.$298K
- Medtronic$163K
- Neurovasc Technologies, Inc.$15K
- plus $11K from 2 others
What the payments were for
- Consulting fees$1,813,79094%
- Speaking & faculty fees$64,4543%
- Travel & lodging$49,3563%
- Food & beverage$6,6980%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 160 | $1,085,594 |
| Stryker | 39 | $404,255 |
| Genentech, Inc. | 24 | $164,046 |
| Siemens Medical Solutions USA, Inc. | 4 | $148,236 |
| AstraZeneca | 36 | $40,252 |
| Silk Road Medical, Inc. | 13 | $24,750 |
| Amgen | 4 | $22,203 |
| Medtronic(3 entities) | 26 | $11,426 |
| Astrazeneca UK Limited | 4 | $8,085 |
| Penumbra, Inc. | 4 | $6,372 |
| Shionogi Inc | 3 | $4,230 |
| Argenx US, Inc. | 1 | $3,450 |
| AbbVie | 2 | $3,025 |
| Balt USA, LLC | 2 | $2,544 |
| MIVI Neuroscience, Inc. | 5 | $2,167 |
| F. Hoffmann-la Roche AG | 4 | $1,767 |
| Olea Medical | 2 | $762 |
| Hyperfine Operations, Inc. | 1 | $600 |
| Phenox Inc. | 3 | $207 |
| Astrazeneca AB | 4 | $153 |
| Rapid Medical Ltd | 1 | $122 |
| Johnson & Johnson | 1 | $30 |
| EMD Serono Research & Development Institute, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Embotrap$839,600
- TREVO$385,637
- TNKase$165,567
- Activase$99,867
- Cathflo Activase$98,100
- CorPath Imaging System$87,000
- EMBOGUARD$60,376
- BRILINTA$42,327
- SPOTLIGHT$27,950
- ENROUTE Transcarotid Neuroprotection System$25,500
- ENROUTE Transcarotid Stent$24,750
- Repatha$22,203
- EMBOTRAP II Revascularization Device$13,950
- WINGSPAN$11,675
- Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$9,163
- TRUFILL$9,163
- Pipeline$7,053
- Penumbra System$6,372
- LOKELMA$2,148
- DAC$1,600
How this compares
$1,934,302 in reported general payments places this provider in the 95th percentile of 1,996 neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $25,052 |
| Atorvastatin Calcium | 51 | $858 |
| ClopidogrelClopidogrel Bisulfate | 35 | $459 |
Paid to pharmacies, not to this prescriber.
Other neurology in Los Angeles
- Perry ShiehLos Angeles$2.4M
- John SternLos Angeles$999K
- Jeffrey CummingsLos Angeles$918K
- Alan RapoportLos Angeles$808K
- Alon AvidanLos Angeles$505K
- Mark LewLos Angeles$450K
- Dawn EliashivLos Angeles$364K
- Richard LewisLos Angeles$309K
- Margaret BurnettLos Angeles$293K
- Michele TagliatiLos Angeles$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.